An intercalation mechanism as a mode of action exerted by psychotropic drugs: Results of altered phospholipids substrate availabilities in membranes?

Journal of Chemical Biology

Volumn 3, Issue 2, 2010, Pages 67-88

  Oruch, Ramadhan ^a   Lund, Anders ^b   Pryme, Ian F ^a   Holmsen, Holm ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cholesterol; Human platelets; MLC; NSAIDs; PET. fMRI; PLA 2; PPI cycle; Psychotropic drugs; PUFAs; Solid stateNMR; SPECT

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ESSENTIAL FATTY ACID; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PHOSPHOLIPID; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGRANULOCYTOSIS; AKATHISIA; ANXIETY DISORDER; BRAIN FUNCTION; CELL MEMBRANE; DEPRESSION; DIET; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DRUG MECHANISM; DYSTONIA; ELECTROCARDIOGRAPHY; ELECTROCONVULSIVE THERAPY; ENZYME SUBSTRATE; HEREDITY; HUMAN; LANGMUIR BLODGETT FILM; LIPID COMPOSITION; LIPID METABOLISM; MEMBRANE FLUIDITY; NEUROLEPTIC MALIGNANT SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSONISM; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; STROKE; SUICIDE ATTEMPT; TARDIVE DYSKINESIA; TURNOVER TIME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 77954563005     PISSN: 18646158     EISSN: 18646166     Source Type: Journal    
DOI: 10.1007/s12154-009-0034-6     Document Type: Review

References (195)

1. Aberg-Wistedt A (1989) The antidepressant effects of 5-HT uptake inhibitors. Br J Psychiatry 8:32-40
2. Andersen G, Vestergaard K, Riis JO (1993) Citalopram for poststroke pathological crying. Lancet 342(8875):837-839
3. Atmaca M, Kuloglu M, Tezcan E, Semercioz A (2002) The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res 14(6):502-505
4. Balasubramanian K, Mirnikjoo B, Schroit AJ (2007) Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J Biol Chem 282(25):18357-18364
5. Barbosa NR, Junqueira RM, Vallada HP, Gattaz WF (2007) Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. Eur Arch Psychiatry Clin Neurosci 257(6):340-343
6. Barenholz Y (2002) Cholesterol and other membrane active sterols: from membrane evolution to "rafts". Prog Lipid Res 41 (1):1-5
7. Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, Pernet DE, Kirkbride JB, Murray GK, Bullmore ET, Jones PB (2007) Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 190:515-520
8. Bechter K (2004) The mild encephalitis-hypothesis-new findings and studies. Psychiatr Prax 31(Suppl 1):S41-S43
9. Bechter K, Schreiner V, Herzog S, Breitinger N, Wollinsky KH, Brinkmeier H, Aulkemeyer P, Weber F, Schuttler R (2003) CSF filtration as experimental therapy in therapyresistant psychoses in borna disease virus-seropositive patients. Psychiatr Prax 30 (Suppl 2):216-220
10. Ben-Shachar D (2002) Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 83(6):1241-1251
11. Benazzi F, Mazzoli M, Rossi E (1993) Auditory hallucinations suppressed by etizolam in a patient with schizophrenia. Can J Psychiatry 38(8):574-575
12. Bennouna M, Greene VB, Defranoux L (2007) Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: a link? Encephale 33(4 Pt 1):616-620
13. Berger GE, Smesny S, Amminger GP (2006) Bioactive lipids in schizophrenia. Int Rev Psychiatry 18(2):85-98
14. Blob LF, Sharoky M, Campbell BJ, Kemper EM, Gilmor MG, VanDenberg CM, Azzaro AJ (2007) Effects of a tyramineenriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour. CNS Spectr 12(1):25-34
15. Boon C, Walker H (2006) Davidsońs priciples & practice of medicine, Chapter 10, 20th edn. Churchill Livingstone, Edinburgh
16. Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pfluger MO, Stieglitz RD, Radue EW, Riecher-Rossler A (2008)Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res 106(2-3):108-114
17. Bose SK, Turkheimer FE, Howes OD, Mehta MA, Cunliffe R, Stokes PR, Grasby PM (2008) Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging. Schizophr Res 106(2-3):148-155
18. Boulenger JP, Capdevielle D (2007) Pharmacological treatment of generalized anxiety disorders: rationale and limitations. Encephale 33(1):84-94
19. Boylan LS (2000) Limbic encephalitis and late-onset psychosis. Am J Psychiatry 157(8):1343-1344
20. Brash AR (1999) Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 274(34):23679-23682
21. Bretscher MS (1972) Phosphatidyl-ethanolamine: differential labelling in intact cells and cell ghosts of human erythrocytes by a membrane-impermeable reagent. J Mol Biol 71(3):523-528
22. Brindley DN (1984) Intracellular translocation of phosphatidate phosphohydrolase and its possible role in the control of glycerolipid synthesis. Prog Lipid Res 23(3):115-133
23. Brown JS Jr (2001) A novel mechanism to explain protein abnormalities in schizophrenia based on the flavivirus resistance gene. Mol psychiatry 6(6):701-711
24. Brown DA, Rose JK (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68(3):533-544
25. Buretic-Tomljanovic A, Giacometti J, Nadalin S, Rubesa G, Vulin M, Tomljanovic D (2008) Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia. Psychiatr Danub 20(3):372-383
26. Butikofer P, Lin ZW, Chiu DT, Lubin B, Kuypers FA (1990) Transbilayer distribution and mobility of phosphatidylinositol in human red blood cells. J Biol Chem 265(27):16035-16038
27. Bymaster FP, Hemrick-Luecke SK, Perry KW, Fuller RW (1996) Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology (Berl) 124(1-2):87-94
28. Bymaster FP, Nelson DL, DeLapp NW, Falcone JF, Eckols K, Truex LL, Foreman MM, Lucaites VL, Calligaro DO (1999) Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro. Schizophr Res 37(1):107-122
29. Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Breier AF (1999) Diazepam treatment of early signs of exacerbation in schizophrenia. Am J Psychiatry 156(2):299-303
30. Carrera N, Sanjuan J, Molto MD, Carracedo A, Costas J (2009) Recent adaptive selection at MAOB and ancestral susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 150B(3):369-374
31. Carter CJ (2009) Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, Herpes simplex, Rubella, and Toxoplasma gondii. Schizophr Bull 35(6):1163-1182
32. Chance SA, Casanova MF, Switala AE, Crow TJ (2008) Auditory cortex asymmetry, altered minicolumn spacing and absence of ageing effects in schizophrenia. Brain 131(Pt 12):3178-3192
33. Chen CH, Lennox B, Jacob R, Calder A, Lupson V, Bisbrown- Chippendale R, Suckling J, Bullmore E (2006) Explicit and implicit facial affect recognition in manic and depressed States of bipolar disorder: a functional magnetic resonance imaging study. Biol Psychiatry 59(1):31-39
34. Chen S, Gjerde AU, Holmsen H, Nerdal W (2005) Importance of polyunsaturated acyl chains in chlorpromazine interaction with phosphatidylserines: a 13C and 31P solid-state NMR study. Biophys Chemist 117(2):101-109
35. Chen Y, Grossman ED, Bidwell LC, Yurgelun-Todd D, Gruber SA, Levy DL, Nakayama K, Holzman PS (2008) Differential activation patterns of occipital and prefrontal cortices during motion processing: evidence from normal and schizophrenic brains. Cogn Affect Behav Neurosci 8(3):293-303
36. Christensen L (2001) The effect of food intake on mood. Clinical Nutrition 20(Supplement 1):161-166
37. Cinek T, Horejsi V (1992) The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J Immunol 149(7):2262-2270
38. Coppen A, Rama Rao VA, Swade C, Wood K (1979) Inhibition of 5-hydroxytryptamine reuptake by amitryptyline an zimelidine and its relationship to their therapeutic action. Psychopharmacology (Berl) 63(2):125-129
39. da Prada M, Tranzer JP, Pletscher A (1967) Effect of drugs and cations on ultrastructure and 5-hydroxytryptamine content of blood platelets. J Pharmacol Exp Ther 158(3):394-398
40. Daleke DL (2003) Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 44(2):233-242
41. Daniel JL, Molish IR, Holmsen H (1981) Myosin phosphorylation in intact platelets. J Biol Chem 256(14):7510-7514
42. Daniel WA, Wojcikowski J, Palucha A (2001) Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br J Pharmacol 134 (4):807-814
43. De Camilli P, Emr SD, McPherson PS, Novick P (1996) Phosphoinositides as regulators in membrane traffic. Science 271(5255):1533-1539
44. De Keyser J, Mostert JP, Koch MW (2008) Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J Neurol Sci 267(1-2):3-16
45. de Kruijff B, Cullis PR (1980) The influence of poly(Llysine) on phospholipid polymorphism. Evidence that electrostatic polypeptide-phospholipid interactions can modulate bilayer/non-bilayer transitions. Biochim Biophys Acta 601 (1):235-240
46. Degenhardt L, Roxburgh A, McKetin R (2007) Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia. Med J Aust 186(7):342-345
47. Dietrich C, Bagatolli LA, Volovyk ZN, Thompson NL, Levi M, Jacobson K, Gratton E (2001) Lipid rafts reconstituted in model membranes. Biophys J 80(3):1417-1428
48. Dietrich-Muszalska A, Olas B (2009) The changes of aggregability of blood platelets in schizophrenia. World J Biol Psychiatry 10 (2):171-176
49. Dufourc EJ (2008) Sterols and membrane dynamics. Journal of Chemical Biology 1(1-4):63-77
50. Dykstra M, Cherukuri A, Sohn HW, Tzeng SJ, Pierce SK (2003) Location is everything: lipid rafts and immune cell signaling. Annu Rev Immunol 21:457-481
51. Edidin M (2003) The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 32:257-283
52. Emmerson PJ, Clark MJ, Medzihradsky F, Remmers AE (1999) Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy. J Neurochem 73 (1):289-300
53. Esposito E, Di Matteo V, Di Giovanni G (2008) Serotonindopamine interaction: an overview. Prog Brain Res 172:3-6
54. Fazel S, Grann M, Ahlner J, Goodwin G (2007) Suicides by violent means in individuals taking SSRIs and other antidepressants: a postmortem study in Sweden, 1992-2004. J Clin Psychopharmacol 27(5):503-506
55. Fenton WS, Hibbeln J, Knable M (2000) Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47(1):8-21
56. Fleminger S (2008) Long-term psychiatric disorders after traumatic brain injury. Eur J Anaesthesiol Suppl 42:123-130
57. Fourcade O, Simon MF, Viode C, Rugani N, Leballe F, Ragab A, Fournie B, Sarda L, Chap H (1995) Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80 (6):919-927
58. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294(5548):1871-1875
59. Gardner A, Boles RG (2008) Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression. Biopsychosoc Med 2:7
60. Garland EJ, Zis AP (1991) Multiple sclerosis and affective disorders. Can J Psychiatry 36(2):112-117
61. Gattaz WF, Schmitt A, Maras A (1995) Increased platelet phospholipase A2 activity in schizophrenia. Schizophr Res 16(1):1-6
62. Gemperle AY, Enz A, Pozza MF, Luthi A, Olpe HR (2003) Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study. Neuroscience 117 (3):681-695
63. Goldchluk A, Herbst L (2008) Permanent psychiatric effects in former addicts to marijuana or stimulants. Vertex XIX(77):503-511
64. Grunder G, Fellows C, Janouschek H, Veselinovic T, Boy C, Brocheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, Rosch F, Schaefer WM, Vernaleken I (2008) Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study. Am J Psychiatry 165(8):988-995
65. Haines TH (2001) Do sterols reduce proton and sodium leaks through lipid bilayers? Prog Lipid Res 40(4):299-324
66. Hall W, Degenhardt L (2006) What are the policy implications of the evidence on cannabis and psychosis? Can J Psychiatry 51 (9):566-574
67. Hammond CJ, Hobbs JA (2007) Parvovirus B19 infection of brain: possible role of gender in determining mental illness and autoimmune thyroid disorders. Med Hypotheses 69 (1):113-116
68. Harrison G, Whitley E, Rasmussen F, Lewis G, Dalman C, Gunnell D (2006) Risk of schizophrenia and other non-affective psychosis among individuals exposed to head injury: case control study. Schizophr Res 88(1-3):119-126
69. Harrison P, Geddes J, Sharpe M (2005) Psychiatry:lecture notes, 9th edn. Blackwell, Massachusetts
70. Hathaway DR, Adelstein RS (1979) Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. Proc Natl Acad Sci U S A 76(4):1653-1657
71. Hatta K, Miyakawa K, Ota T, Usui C, Nakamura H, Arai H (2007) Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. J Ect 23(4):233-235
72. Heijnen HF, Van Lier M, Waaijenborg S, Ohno-Iwashita Y, Waheed AA, Inomata M, Gorter G, Mobius W, Akkerman JW, Slot JW (2003) Concentration of rafts in platelet filopodia correlates with recruitment of c-Src and CD63 to these domains. J Thromb Haemost 1(6):1161-1173
73. Hibbeln JR (1998) Fish consumption and major depression. Lancet 351(9110):1213
74. Hietala J, Syvalahti E, Vilkman H, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Eronen E, Ruotsalainen U, Salokangas RK (1999) Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res 35(1):41-50
75. Holland JW, Hui C, Cullis PR, Madden TD (1996) Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry 35(8):2618-2624
76. Holmsen H, Daniel JL, Dangelmaier CA, Molish I, Rigmaiden M, Smith JB (1984) Differential effects of trifluoperazine on arachidonate liberation, secretion and myosin phosphorylation in intact platelets. Thromb Res 36(5):419-428
77. Holthuis JC, Levine TP (2005) Lipid traffic: floppy drives and a superhighway. Nat Rev Mol Cell Biol 6(3):209-220
78. Hoschl C, Svestka J (2008) Escitalopram for the treatment of major depression and anxiety disorders. Expert Rev Neurother 8 (4):537-552
79. Huang C, Li S (1999) Calorimetric and molecular mechanics studies of the thermotropic phase behavior of membrane phospholipids. Biochim Biophys Acta 1422(3):273-307
80. Huang TL (2005) Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia. Psychiatry Clin Neurosci 59(1):52-55
81. Huang Y, Zhao Q, Chen GQ (2006) Phospholipid scramblase 1. Sheng Li Xue Bao 58(6):501-510
82. Hulbert AJ, Turner N, Storlien LH, Else PL (2005) Dietary fats and membrane function: implications for metabolism and disease. Biol Rev Camb Philos Soc 80(1):155-169
83. Hung YY, Huang TL (2006) Lorazepam and diazepam rapidly relieve catatonic features in major depression. Clin Neuropharmacol 29(3):144-147
84. Ilniczky S, Debreczeni R, Kovacs T, Varkonyi V, Barsi P, Szirmai I (2006) Aids-related toxoplasma-encephalitis presenting with acute psychotic episode. Ideggyogy Sz 59(7-8):289-293
85. Isacsson G, Bejerot S, Jarbin H (2007) Fewer children are treated with SSRI, more commit suicide. Alarming trend among children and adolescents in USA. Lakartidningen 104 (43):3180-3181
86. Janas-Kozik M, Stachowicz M, Mazurek U, Zajdel A, Wilczok A, Krupka-Matuszczyk I, Rybakowski JK (2008) Preliminary study of the expression of genes connected with the orexigenic and anorexigenic system using microarray technique in anorexia nervosa. Neuropsychobiology 57(3):116-120
87. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen FE, Prusiner SB (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A 94 (19):10069-10074
88. Kang JI, Kim JJ, Seok JH, Chun JW, Lee SK, Park HJ (2009) Abnormal brain response during the auditory emotional processing in schizophrenic patients with chronic auditory hallucinations. Schizophr Res 107(1):83-91
89. Kato N, Nakanishi M, Hirashima N (2002) Transbilayer asymmetry of phospholipids in the plasma membrane regulates exocytotic release in mast cells. Biochemistry 41(25):8068-8074
90. Katzung BG (2007) Basic and clinical pharmacology. In: Potter WZ, Hollister LE (eds) Antipsychotic agents & lithium, 10th edn. McGraw-Hill, Sydney, pp 457-474
91. Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A (2008) Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology 33(13):3111-3125
92. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51(1):8-19
93. Koene S, Kozicz TL, Rodenburg RJ, Verhaak CM, de Vries MC, Wortmann S, van de Heuvel L, Smeitink JA, Morava E (2009) Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J Affect Disord 114 (1-3):327-332
94. Kohlrausch FB, Gama CS, Lobato MI, Belmonte-de-Abreu P, Callegari-Jacques SM, Gesteira A, Barros F, Carracedo A, Hutz MH (2008) Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European-Brazilian schizophrenics. Pharmacogenet Genomics 18(7):599-609
95. Kringlen E, Torgersen S, Cramer V (2006) Mental illness in a rural area: a Norwegian psychiatric epidemiological study. Soc Psychiatry Psychiatr Epidemiol 41(9):713-719
96. Kucharska-Pietura K, Pietura R, Masiak M (2001) Neural correlates of emotions in psychiatric patients in the light of functional neuroimaging findings. Ann Univ Mariae Curie Sklodowska [Med] 56:343-348
97. Kuroda YKK (1984) Intra- and intermolecular 1H-1H nuclear overhauser effect studies on the interactions of chlorpromazine with lecithin vesicles. J Am Chem Soc 106:1-6
98. Lee KJ, Lee JS, Kim SJ, Correll CU,Wee H, Yoo SY, Jeong JM, Lee DS, Lee SI, Kwon JS (2008) Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia. Acta Psychiatr Scand 118(3):200-208
99. Leucht S, Pitschel-Walz G, Engel RR, Kissling W (2002) Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials. Am J Psychiatry 159(2):180-190
100. Levy JV (1983) Calmodulin antagonists inhibit aggregation of human, guniea pig and rabbit platelets induced with platelet activating factor. FEBS Lett 154(2):262-264
101. Lewis RN, Mannock DA, McElhaney RN, Turner DC, Gruner SM (1989) Effect of fatty acyl chain length and structure on the lamellar gel to liquid-crystalline and lamellar to reversed hexagonal phase transitions of aqueous phosphatidylethanolamine dispersions. Biochemistry 28(2):541-548
102. Lingjaerde O (1969) Uptake of serotonin in blood platelets: dependence on sodium and chloride, and inhibition by choline. FEBS Lett 3(2):103-106
103. Lingjaerde O (1980) Antidepressants and the serotonin uptake in platelets. Acta Psychiatr Scand Suppl 280:111-119
104. Lingjaerde O (1991) Benzodiazepines in the treatment of schizophrenia: an updated survey. Acta Psychiatr Scand 84(5):453-459
105. Lingjaerde O (2006) Psykofarmaka, 5th edn. Norwegian Academic, Oslo
106. Lingjaerde O Jr (1971) Uptake of serotonin in blood platelets in vitro. 3. Effects of acetate and other monocarboxylic acids. Acta Physiol Scand 83(3):309-318
107. Lingjaerde O Jr (1971) Uptake of serotonin in blood platelets in vitro. I. The effects of chloride. Acta Physiol Scand 81(1):75-83
108. Lingjaerde O Jr (1971) Uptake of serotonin in blood platelets in vitro. II. Further studies on the effects of small anions. Acta Physiol Scand 83(2):257-268
109. Lloyd AJ, Grace JB, Jaros E, Perry RH, Fairbairn AF, Swann AG, OBrien JT, McKeith IG (2001) Depression in late life, cognitive decline and white matter pathology in two clinicopathologically investigated cases. Int J Geriatr Psychiatry 16 (3):281-287
110. Loftis JM, Huckans M, Ruimy S, Hinrichs DJ, Hauser P (2008) Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett 430(3):264-268
111. London E (2002) Insights into lipid raft structure and formation from experiments in model membranes. Curr Opin Struct Biol 12 (4):480-486
112. Madden TD, Cullis PR (1982) Stabilization of bilayer structure for unsaturated phosphatidylethanolamines by detergents. Biochim Biophys Acta 684(1):149-153
113. Malmgren R, Aberg-Wistedt A, Bertilsson L (1987) Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolites. Psychopharmacology (Berl) 92(2):169-172
114. Mamalakis G, Tornaritis M, Kafatos A (2002) Depression and adipose essential polyunsaturated fatty acids. Prostaglandins, Leukot Essent Fat Acids 67(5):311-318
115. Manes S, del Real G, Martinez AC (2003) Pathogens: raft hijackers. Nat Rev Immunol 3(7):557-568
116. Marshall EF, Stirling GS, Tait AC, Todrick A (1960) The effect of iproniazid and imipramine on the blood platelet 5-hydroxytrptamine level in man. Br J Pharmacol Chemother 15:35-41
117. Martin T (1998) Phosphoinisitide lipids as signalling molecules: common themes for signal transduction, cytoskeletal regulation, and membrane traficking. Annu Rev Cell Dev Biology 14:231-264
118. Mayor S, Rao M (2004) Rafts: scale-dependent, active lipid organization at the cell surface. Traffic 5(4):231-240
119. McConnell HM, Vrljic M (2003) Liquid-liquid immiscibility in membranes. Annu Rev Biophys Biomol Struct 32:469-492
120. Meltzer HY (1995) The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics. J Clin Psychopharmacol 15(1 Suppl 1):2S-3S
121. Meltzer HY, Huang M (2008) In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog Brain Res 172:177-197
122. Mendlewicz J, Souery D (1995) Heredity and manic-depressive psychosis. Bull Acad Natl Med 179(4):755-764 discussion 764-1756
123. Mitchell IJ, Cooper AC, Griffiths MR, Cooper AJ (2002) Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat. Neuroscience 109 (1):89-99
124. Moretti A, Gorini A, Villa RF (2003) Affective disorders, antidepressant drugs and brain metabolism. Mol Psychiatry 8 (9):773-785
125. Mouritsen OG, Jorgensen K (1994) Dynamical order and disorder in lipid bilayers. Chem Phys Lipids 73(1-2):3-25
126. Munro S (2003) Lipid rafts: elusive or illusive? Cell 115(4):377-388
127. Nerdal W, Gundersen SA, Thorsen V, Hoiland H, Holmsen H (2000) Chlorpromazine interaction with glycerophospholipid liposomes studied by magic angle spinning solid state (13)CNMR and differential scanning calorimetry. Biochim Biophys Acta 1464(1):165-175
128. Noponen M, Sanfilipo M, Samanich K, Ryer H, Ko G, Angrist B, Wolkin A, Duncan E, Rotrosen J (1993) Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry 34(9):641-649
129. Op den Kamp JA (1979) Lipid asymmetry in membranes. Annu Rev Biochem 48:47-71
130. Oruch R, Hodneland E, Pryme IF, Holmsen H (2008) Psychotropic drugs interfere with the tight coupling of polyphosphoi-nositide cycle metabolites in human platelets: a result of receptor-independent drug intercalation in the plasma membrane? Biochim Biophys Acta 1778(10):2165-2176
131. Oruch R, Pryme IF, Holmsen H (2008) Effects of psychotropic drugs on the thrombin-induced liberation of arachidonate in human platelets. Saudi Med J 29(10):1397-1407
132. Oruch R, Hodneland E, Pryme IF, Holmsen H (2009) In thrombin stimulated human platelets Citalopram, Promethazine, Risperidone, and Ziprasidone, but not Diazepam, may exert their pharmacological effects also through intercalation in membrane phospholipids in a receptor-independent manner. Journal of Chemical Biology 2(2):89-103
133. Parellada E, Lomena F, Font M, Pareto D, Gutierrez F, Simo M, Fernandez-Egea E, Pavia J, Ros D, Bernardo M (2008) Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation. Nucl Med Commun 29(10):894-900
134. Parks JS, Huggins KW, Gebre AK, Burleson ER (2000) Phosphatidylcholine fluidity and structure affect lecithin:cholesterol acyltransferase activity. J Lipid Res 41(4):546-553
135. Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43(5):315-319 (Pubitemid 28137622)
136. Pennington K, Dicker P, Hudson L, Cotter DR (2008) Evidence for reduced neuronal somal size within the insular cortex in schizophrenia, but not in affective disorders. Schizophr Research 106(2-3):164-171
137. Perroud N, Baud P, Preisig M, Etain B, Bellivier F, Favre S, Reber N, Ferrero F, Leboyer M, Malafosse A (2007) Social phobia is associated with suicide attempt history in bipolar inpatients. Bipolar Disord 9(7):713-721
138. Pilowsky LS, Ring H, Shine PJ, Battersby M, Lader M (1992) Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital. Br J Psychiatry 160:831-835
139. Pohorille A, Wilson MA, New MH, Chipot C (1998) Concentrations of anesthetics across the water-membrane interface; the Meyer-Overton hypothesis revisited. Toxicol Lett 100-101:421-430
140. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9(7):684-697 643 (Pubitemid 38932173)
141. Rahme E, Dasgupta K, Turecki G, Nedjar H, Galbaud du Fort G (2008) Risks of suicide and poisoning among elderly patients prescribed selective serotonin reuptake inhibitors: a retrospective cohort study. J Clin Psychiatry 69(3):349-357
142. Rao V, Spiro J, Vaishnavi S, Rastogi P, Mielke M, Noll K, Cornwell E, Schretlen D, Makley M (2008) Prevalence and types of sleep disturbances acutely after traumatic brain injury. Brain Inj 22(5):381-386
143. Ricci A, Bronzetti E, Mannino F, Mignini F, Morosetti C, Tayebati SK, Amenta F (2001) Dopamine receptors in human platelets. Naunyn Schmiedebergs Arch Pharmacol 363(4):376-382
144. Ross BM, Hughes B, Kish SJ, Warsh JJ (2006) Serum calciumindependent phospholipase A2 activity in bipolar affective disorder. Bipolar Disord 8(3):265-270
145. Rothman JE, Lenard J (1977) Membrane asymmetry. Science 195(4280):743-753
146. Rotman A, Shatz A, Szekely GA (1982) Correlation between serotonin uptake and imipramine binding in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 6(1):57-61
147. Rudnick G (1977) Active transport of 5-hydroxytryptamine by plasma membrane vesicles isolated from human blood platelets. J Biol Chem 252(7):2170-2174
148. Saarto T, Wiffen PJ (2007) Antidepressants for neuropathic pain. Cochrane Database Syst Rev 4:CD005454
149. Schedel A, Schloss P, Kluter H, Bugert P (2008) The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors. Naunyn Schmiedebergs Arch Pharmacol 378(4):431-439
150. Schmitt GJ, la Fougere C, Dresel S, Frodl T, Hahn K, Moller HJ, Meisenzahl EM (2008) Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naive schizophrenic patients. Schizophr Res 101(1-3):133-141
151. Schneiter R, Brugger B, Sandhoff R, Zellnig G, Leber A, Lampl M, Athenstaedt K, Hrastnik C, Eder S, Daum G, Paltauf F,Wieland FT, Kohlwein SD (1999) Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chainbased sorting/remodeling of distinctmolecular species en route to the plasma membrane. J cell Biol 146(4):741-754
152. Seal ML, Yucel M, Fornito A, Wood SJ, Harrison BJ, Walterfang M, Pell GS, Pantelis C (2008) Abnormal white matter microstructure in schizophrenia: a voxelwise analysis of axial and radial diffusivity. Schizophr Res 101(1-3):106-110
153. Seddon AM, Curnow P, Booth PJ (2004) Membrane proteins, lipids and detergents: not just a soap opera. Biochim Biophys Acta 1666(1-2):105-117
154. Seeman P, Corbett R, Van Tol HH (1997) Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16(2):93-110 discussion 111-135
155. Silvers KM, Scott KM (2002) Fish consumption and selfreported physical and mental health status. Public Health Nutr 5(3):427-431
156. Simons K, Vaz WL (2004) Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 33:269-295
157. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF (1992) The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 52(5):547-552
158. Singer SJ, Nicolson GL (1972) The fluid mosaic model of the structure of cell membranes. Science 175(23):720-731
159. Singh RK, Ethayathulla AS, Jabeen T, Sharma S, Kaur P, Singh TP (2005) Aspirin induces its anti-inflammatory effects through its specific binding to phospholipase A2: crystal structure of the complex formed between phospholipase A2 and aspirin at 1.9 angstroms resolution. J Drug Target 13(2):113-119
160. Sivrioglu EY, Kirli S, Sipahioglu D, Gursoy B, Sarandol E (2007) The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study. Prog Neuropsychopharmacol Biol Psychiatry 31 (7):1493-1499
161. Six DA, Dennis EA (2000) The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 1488(1-2):1-19
162. Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271(52):33157-33160
163. Smoller JW, Gardner-Schuster E, Covino J (2008) The genetic basis of panic and phobic anxiety disorders. Am J Med Genet C Semin Med Genet 148(2):118-126
164. Souery D, Mendelbaum K, Mendlewicz J (1994) Genetics and manic-depressive psychosis: review and current findings. Acta Psychiatr Belg 94(3):134-150
165. Stahl SM (1996) Essential psychopharmacology. Cambridge University Press, Cambridge
166. Stahl SM, Meltzer HY (1978) A kinetic and pharmacologic analysis of 5-hydroxytryptamine transport by human plateletsand platelet storage granules: comparison with central serotonergic neurons. J Pharmacol Exp Ther 205(1):118-132
167. Stein DJ, Muller J (2008) Cognitive-affective neuroscience of somatization disorder and functional somatic syndromes: reconceptualizing the triad of depression-anxiety-somatic symptoms. CNS Spectr 13(5):379-384
168. Stone JM, Davis JM, Leucht S, Pilowsky LS (2009) Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs-an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature. Schizophr Bull 35(4):789-797
169. Sun GY, Xu J, Jensen MD, Simonyi A (2004) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 45(2):205-213
170. Sunshine C, McNamee MG (1994) Lipid modulation of nicotinic acetylcholine receptor function: the role of membrane lipid composition and fluidity. Biochim Biophys Acta 1191(1):59-64
171. Takahashi Y (1954) An enzymological study on brain tissue of schizophrenic patients. Carbohydrate metabolism. Folia Psychiatrica Neurol Jpn 7:214-237
172. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H (2001) Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 58 (5):512-513
173. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J, Vartiainen E (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatric services Washington, D.C 52(4):529-531
174. Tharmapathy P, Fukami MH, Holmsen H (2000) The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin. Biochem Pharmacol 60(9):1267-1277
175. Tharmapathy P, Selheim F, Odegaard K, Lund A, Holmsen H (2000) Venlafaxine treatment stimulates blood platelet activity. J Clin Psychopharmacol 20(5):589-590
176. Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM (2003) Plasma fatty acid composition and depression are associated in the elderly: the
177. Toker A (1998) The synthesis and cellular roles of phosphatidylinositol 4, 5-bisphosphate. Curr Opin Cell Biol 10(2): 254-261
178. TokerA, Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387(6634):673-676
179. Tsegaye Y, Daasvatn KO, Holmsen H (2002) Acyl specificity of phospholipases A2 and C in thrombin-stimulated human platelets. Platelets 13(1):31-35
180. Tysnes OB, Steen VM, Frolich KW, Holmsen H (1990) Evidence that chlorpromazine and prostaglandin E1 but not neomycin interfere with the inositol phospholipid metabolism in intact human platelets. FEBS Lett 264(1):33-36
181. Videbech P (1997) MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr Scand 96(3):157-168
182. Videbech P (2000) PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 101(1):11-20
183. Vollmert C, Tost H, Brassen S, Jatzko A, Braus DF (2004) Depression and modern neuroimaging. Fortschr Neurol Psychiatr 72(8):435-445
184. Willis J, Marks J (1993) Lecture notes on psychiatry. Blackwell, London
185. Wong ML, Dong C, Maestre-Mesa J, Licinio J (2008) Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Molecular psychiatry 13(8):800-812
186. Wood MD, Wren PB (2008) Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Prog Brain Res 172:213-230
187. Wood PL, Suranyi-Cadotte BE, Nair NP, LaFaille F, Schwartz G (1983) Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients. Neuropharmacology 22(10):1211-1214
188. Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W, Li X, Dyck LE, Devon RM, Deng Y, Li XM (2008) Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry 13(7):697-708
189. Yalueth I, Alemdar M, Tufan AE, Kirmizi-Alsan E, Kutlu H (2008) Limbic encephalitis presenting with anxiety and depression: a comprehensive neuropsychological formulation. World J Biol Psychiatry 29:1-4
190. Yao JK, Leonard S, Reddy RD (2000) Membrane phospholipids abnormalities in postmortem brains from schizophrenic patients. Schizophr Res 42(1):7-17
191. Yolken RH, Torrey EF (2008) Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 13(5):470-479
192. Yoon HK, Kim YK (2008) Association between serotoninrelated gene polymorphisms and suicidal behavior in depressive patients. Prog Neuro-Psychopharmacol Biol Psychiatry 32 (5):1293-1297
193. Zachowski A (1993) Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 294(Pt 1):1-14
194. Zeldin DC (2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276(39):36059-36062
195. Zwaal RF, Comfurius P, Bevers EM (2005) Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 62 (9):971-988